PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization
- Conditions
- Pneumococcal Infections
- Interventions
- Biological: 13-valent Pneumococcal Conjugate VaccineBiological: 7 valent pneumococcal conjugate vaccine
- First Posted Date
- 2007-07-30
- Last Posted Date
- 2013-05-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1866
- Registration Number
- NCT00508742
- Locations
- 🇮🇱
Pfizer Investigational Site, Segev Shalom, Israel
🇮🇱Pfizer Investigational Sites (7), Beer-Sheva, Israel
Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay
- Conditions
- Healthy
- Interventions
- Procedure: Large volume blood draw
- First Posted Date
- 2007-07-30
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 152
- Registration Number
- NCT00508950
- Locations
- 🇺🇸
Frontage Clinical Services Inc., Secaucus, New Jersey, United States
Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery
- Conditions
- Postoperative Pain
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 277
- Registration Number
- NCT00507026
- Locations
- 🇺🇸
American Institute of Healthcare and Fitness, Raleigh, North Carolina, United States
🇺🇸University Orthopedics Center, State College, Pennsylvania, United States
🇺🇸Arizona Research Center, Phoenix, Arizona, United States
A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak
- Conditions
- Postherpetic Neuralgia
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2012-06-07
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00506610
- Locations
- 🇺🇸
Plains Medical Clinic, Fargo, North Dakota, United States
🇺🇸Odyssey Research, Spokane, Washington, United States
🇺🇸Bradenton Research Center, Bradenton, Florida, United States
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2007-07-18
- Last Posted Date
- 2017-02-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 684
- Registration Number
- NCT00503139
- Locations
- 🇯🇵
Hokkaido University Hospital, Sapporo, Japan
TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
- Conditions
- Encephalitis, Tick-Borne
- First Posted Date
- 2007-07-18
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 314
- Registration Number
- NCT00503529
- Locations
- 🇵🇱
Hospital in Debica - Zespol Opieki Zdrowotnej w Debicy, Debica, Poland
🇵🇱Szpital Jana Pawla II (The John Paul II Hospital) Oddzial Neuroinfekcji, Krakow, Poland
Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus
- First Posted Date
- 2007-07-17
- Last Posted Date
- 2014-08-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 229
- Registration Number
- NCT00502242
- Locations
- 🇿🇦
Pfizer Investigational Site, Cape Town, Western Cape, South Africa
Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects
- Conditions
- Pneumococcal Infections
- Interventions
- Biological: 13-valent Pneumococcal Conjugate Vaccine (13vPnC)
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2011-09-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1053
- Registration Number
- NCT00500266
Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
- Conditions
- Alzheimer Disease
- Interventions
- Biological: ACC-001 + QS-21Biological: QS-21Biological: ACC-001
- First Posted Date
- 2007-07-10
- Last Posted Date
- 2016-01-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 160
- Registration Number
- NCT00498602
- Locations
- 🇺🇸
Barnes-Jewish Hospital, St. Louis, Missouri, United States
🇺🇸Barrnes-Jewish Hospital at Washington University, St. Louis, Missouri, United States
🇺🇸CUMC Research Pharmacy, New York, New York, United States
Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis
- Conditions
- Candidiasis
- Interventions
- First Posted Date
- 2007-07-04
- Last Posted Date
- 2011-10-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 282
- Registration Number
- NCT00496197
- Locations
- 🇰🇷
Pfizer Investigational Site, Seoul, Korea, Republic of